USPH - U.S. Physical Therapy Price-to-Revenue Coefficient

Symbol and logo of brand usph.com (USPH)

The price-to-sales trend for U.S. Physical Therapy (USPH) on GURU.Markets captures the valuation dynamics of U.S. Physical Therapy (USPH), where 1.80 reflects the latest metric value. Value growth is driven by expansion through M&A transactions and physician partnerships. Business stability is based on the management of hundreds of rehabilitation centers. However, final margins depend on insurance reimbursement levels and the containment of personnel labor costs.

USPH: usph.com Price-to-Revenue Ratio 07/04/2022 - 11/13/2026

U.S. Physical Therapy (USPH) - metric breakdowns and financial figures

- price and consensus price forecast:
Fundamental company analysis:USPH, US Physical Therapy
Finished products of US Physical Therapy Inc

For U.S. Physical Therapy (USPH), which optimizes costs through decentralized procurement of consumables, the current price-to-sales ratio serves as an indicator of the market value of one dollar of sales. The ratio of market capitalization to total revenue allows for an assessment of the monetization efficiency of the clinic network, where a low multiple signals either an undervalued asset or a systemic slowdown in business growth rates.

Competing companies

Price-to-Revenue Coefficient hcahealthcare.com|Tenet Healthcare Corporation - Market Cap to Revenue|Price-to-Revenue Coefficient Fresenius Medical Care AG (FMS)|SOLV: Market Cap to Revenue|Market Capitalization-to-Revenue Ratio EHC (Encompass)|uhsinc.com (UHS) - Price-to-Revenue Ratio|Price-to-Sales Ratio DVA (davita.com)|RDNT (RadNet) - P/S Multiple|OPCH: Market Capitalization-to-Revenue Ratio|Market Cap to Revenue SGRY (Surgery Partners Corp)|PINC - Price to Sales|Price-to-Revenue Ratio National Vision Holdings EYE|Price-to-Revenue Coefficient progyny.com (PGNY)|Ardent Health Partners - P/S Multiple|Price-to-Revenue Coefficient Select Medical Corporation SEM|ASTH: P/S Multiple|Market Cap to Revenue MEDNAX|PNTG (The Pennant Group, Inc.) - P/S Multiple|P/S Multiple organogenesis.com|Price-to-Revenue Ratio Nutex Health (NUTX)|Price-to-Revenue Ratio AUNA (Auna S.A.)|SBC Medical Group Holdings Inc. - Market Cap to Revenue|Market Capitalization-to-Revenue Ratio EOLS|CYH: Market Cap to Revenue|The Beauty Health - Market Cap to Sales Volume|MDWD: P/S Multiple|Biote - Market Capitalization-to-Revenue Ratio|JYNT (The Joint Corporation) - P/S Multiple|Price to Sales DocGo, Inc DCGO|Price-to-Revenue Ratio P3 Health Partners Inc. (PIII)|GANX (gaintherapeutics.com) - Market Capitalization-to-Revenue Ratio|P/S Multiple EUDA (EUDA Health Holdings Limited)|P/S Multiple Basel Medical BMGL|CLGN - Price-to-Revenue Ratio|Price-to-Sales Ratio CUPR|CCM (Concord Medical Services) - Market Cap to Revenue|Price to Sales ashs.com (AMS)|Market Cap to Revenue MRM|P/S Multiple Avalon GloboCare Corporation|Price-to-Revenue Ratio DIH Holding US Inc. (DHAI)|Price-to-Revenue Coefficient Carmell Corp|Price-to-Revenue Ratio NewGenIvf Group Limited NIVF|ATIP (ATI Physical Therapy Inc.) - Price-to-Sales Ratio|CareMax - P/S Multiple|Market Capitalization-to-Revenue Ratio KDLY (Kindly MD Inc)|MODV (LogistiCare) - Market Cap to Revenue|NVOS: Market Cap to Sales Volume|Price-to-Revenue Ratio SunLink Health Systems Inc.|BACK: Market Capitalization-to-Revenue Ratio